Stone House Investment Management, LLC
Position in AQST — Aquestive Therapeutics, Inc.
CIK 1696497
TUNKHANNOCK, PA
Position in AQST
as of Mar 31, 2026
· filed Apr 22, 2026
Position Value
$4,332
-$2,128 QoQ
Shares Held
1,044
+4.4% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2025
3 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in AQST Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026Stone House Investment Management, LLC holds $54,786 across 15 Drug Manufacturers - Specialty & Generic names. AQST ranks #5 (7.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TAK |
Takeda Pharmaceutical Co Ltd
|
1,077 | $19,946 | |
| 2 | HLN |
Haleon plc
|
663 | $6,636 | |
| 3 | RDY |
Dr Reddys Laboratories Ltd
|
462 | $6,398 | |
| 4 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
123 | $5,922 | |
| 5 | AQST |
Aquestive Therapeutics, Inc.
This page
|
1,044 | $4,332 | |
| 6 | LNTH |
Lantheus Holdings, Inc.
|
41 | $3,109 | |
| 7 | PCRX |
Pacira BioSciences, Inc.
|
102 | $2,305 | |
| 8 | BHC |
Bausch Health Companies Inc.
|
332 | $1,792 |
All Filings in AQST
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $4,332 | 1,044 | Shares | Sole | 2026-04-22 | |
| 2025-12-31 | $6,460 | 1,000 | Shares | Sole | 2026-01-21 | |
| 2025-09-30 | $5,590 | 1,000 | Shares | Sole | 2025-10-27 | |
| No filing history on record for this holder in this stock. | ||||||